Using Pluripotent Stem Cells and Their Progeny as an In Vitro Model to Assess (Developmental) Neurotoxicity

Predictive Toxicology: From Vision to Reality

Volumn , Issue , 2015, Pages 279-320

  Hoelting, Lisa ^a   Leist, Marcel ^a   Stoppini, Luc ^b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

Author keywords

Developmental neurotoxicity (DNT); Embryonic stem cells (ESCs); Human stem cells (hSCs); in vitro assays; Inner cell mass (ICM); Neuroepithelial progenitor (NEP) cells; Neurotoxicity; Pluripotent stem cells (PSCs)

Indexed keywords

EID: 84926405501     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527674183.ch13     Document Type: Chapter

References (254)

1. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science, 282 (5391), 1145-1147.
2. Amit, M., Carpenter, M.K., Inokuma, M.S., Chiu, C.P., Harris, C.P., Waknitz, M.A., Itskovitz-Eldor, J., and Thomson, J.A. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol., 227 (2), 271-278.
3. Ma, D.K., Bonaguidi, M.A., Ming, G.L., and Song, H. (2009) Adult neural stem cells in the mammalian central nervous system. Cell Res., 19 (6), 672-682.
4. Moors, M., Cline, J.E., Abel, J., and Fritsche, E. (2007) ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol. Appl. Pharmacol., 221 (1), 57-67.
5. Colman, A. and Dreesen, O. (2009) Pluripotent stem cells and disease modeling. Cell Stem Cell, 5 (3), 244-247.
6. Merkle, F.T. and Eggan, K. (2013) Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell, 12 (6), 656-668.
7. Reinhardt, P., Schmid, B., Burbulla, L.F., Schondorf, D.C., Wagner, L., Glatza, M., Hoing, S., Hargus, G., Heck, S.A., Dhingra, A., Wu, G., Muller, S., Brockmann, K., Kluba, T., Maisel, M., Kruger, R., Berg, D., Tsytsyura, Y., Thiel, C.S., Psathaki, O.E., Klingauf, J., Kuhlmann, T., Klewin, M., Muller, H., Gasser, T., Scholer, H.R., and Sterneckert, J. (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell, 12 (3), 354-367.
8. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126 (4), 663-676.
9. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C.E., and Eggan, K. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321 (5893), 1218-1221.
10. Kaye, J.A. and Finkbeiner, S. (2013) Modeling Huntington's disease with induced pluripotent stem cells. Mol. Cell. Neurosci., 56, 50-64.
11. Lee, G., Papapetrou, E.P., Kim, H., Chambers, S.M., Tomishima, M.J., Fasano, C.A., Ganat, Y.M., Menon, J., Shimizu, F., Viale, A., Tabar, V., Sadelain, M., and Studer, L. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461 (7262), 402-406.
12. Carvajal-Vergara, X., Sevilla, A., D'Souza, S.L., Ang, Y.S., Schaniel, C., Lee, D.F., Yang, L., Kaplan, A.D., Adler, E.D., Rozov, R., Ge, Y., Cohen, N., Edelmann, L.J., Chang, B., Waghray, A., Su, J., Pardo, S., Lichtenbelt, K.D., Tartaglia, M., Gelb, B.D., and Lemischka, I.R. (2010) Patientspecific induced pluripotent stem-cellderived models of LEOPARD syndrome. Nature, 465 (7299), 808-812.
13. Chow, M.Z., Boheler, K.R., and Li, R.A. (2013) Human pluripotent stem cellderived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res. Ther., 4 (4), 97.
14. Kaufman, D.S., Hanson, E.T., Lewis, R.L., Auerbach, R., and Thomson, J.A. (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 98 (19), 10716-10721.
15. Nakamura, S., Takayama, N., Hirata, S., Seo, H., Endo, H., Ochi, K., Fujita, K.I., Koike, T., Harimoto, K.I., Dohda, T., Watanabe, A., Okita, K., Takahashi, N., Sawaguchi, A., Yamanaka, S., Nakauchi, H., Nishimura, S., and Eto, K. (2014) Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. doi: 10.1016/j.stem.2014.01.011.
16. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K.L., and Tzukerman, M. (2001) Insulin production by human embryonic stem cells. Diabetes, 50 (8), 1691-1697.
17. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292 (5520), 1389-1394.
18. Segev, H., Fishman, B., Ziskind, A., Shulman, M., and Itskovitz-Eldor, J. (2004) Differentiation of human embryonic stem cells into insulinproducing clusters. Stem Cells, 22 (3), 265-274.
19. Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y., and Deng, H. (2009) Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res., 19 (4), 429-438.
20. Boissart, C., Poulet, A., Georges, P., Darville, H., Julita, E., Delorme, R., Bourgeron, T., Peschanski, M., and Benchoua, A. (2013) Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening. Transl. Psychiatry, 3, e294.
21. Di Giorgio, F.P., Boulting, G.L., Bobrowicz, S., and Eggan, K.C. (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALScausing mutation. Cell Stem Cell, 3 (6), 637-648.
22. Perrier, A.L., Tabar, V., Barberi, T., Rubio, M.E., Bruses, J., Topf, N., Harrison, N.L., and Studer, L. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 101 (34), 12543-12548.
23. Bianco, P., Cao, X., Frenette, P.S., Mao, J.J., Robey, P.G., Simmons, P.J., and Wang, C.Y. (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med., 19 (1), 35-42.
24. Daly, W., Yao, L., Zeugolis, D., Windebank, A., and Pandit, A. (2012) A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery. J. R. Soc. Interface, 9 (67), 202-221.
25. Staflin, K., Honeth, G., Kalliomaki, S., Kjellman, C., Edvardsen, K., and Lindvall, M. (2004) Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res., 64 (15), 5347-5354.
26. Schwartz, S.D., Hubschman, J.P., Heilwell, G., Franco-Cardenas, V., Pan, C.K., Ostrick, R.M., Mickunas, E., Gay, R., Klimanskaya, I., and Lanza, R. (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet, 379 (9817), 713-720.
27. Leist, M., Bremer, S., Brundin, P., Hescheler, J., Kirkeby, A., Krause, K.H., Poerzgen, P., Puceat, M., Schmidt, M., Schrattenholz, A., Zak, N.B., and Hentze, H. (2008) The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX, 25 (3), 163-190.
28. Balmer, N.V., Weng, M.K., Zimmer, B., Ivanova, V.N., Chambers, S.M., Nikolaeva, E., Jagtap, S., Sachinidis, A., Hescheler, J., Waldmann, T., and Leist, M. (2012) Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum. Mol. Genet., 21 (18), 4104-4114.
29. Cezar, G.G. (2007) Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? Curr. Opin. Chem. Biol., 11 (4), 405-409.
30. Kadereit, S., Zimmer, B., Thriel, C.van., Hengstler, J.G., and Leist, M. (2012) Compound selection for in vitro modeling of developmental neurotoxicity. Front. Biosci. (Landmark Ed.), 17, 2442-2460.
31. van Thriel, C., Westerink, R.H., Beste, C., Bale, A.S., Lein, P.J., and Leist, M. (2012) Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology, 33 (4), 911-924.
32. Harry, G.J., Billingsley, M., Bruinink, A., Campbell, I.L., Classen, W., Dorman, D.C., Galli, C., Ray, D., Smith, R.A., and Tilson, H.A. (1998) In vitro techniques for the assessment of neurotoxicity. Environ. Health Perspect., 106 (Suppl. 1), 131-158.
33. EFSA (2013) Scientific opinion on the identification of pesticides to be included in cumulative assessment groups on the basis of their toxicological profile. EFSA J., 11 (7), 3293.
34. Boyle, C.A., Decoufle, P., and Yeargin-Allsopp, M. (1994) Prevalence and health impact of developmental disabilities in US children. Pediatrics, 93 (3), 399-403.
35. Harada, M. (1995) Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit. Rev. Toxicol., 25 (1), 1-24.
36. Grandjean, P. and Landrigan, P.J. (2006) Developmental neurotoxicity of industrial chemicals. Lancet, 368 (9553), 2167-2178.
37. Boyle, C.A., Boulet, S., Schieve, L.A., Cohen, R.A., Blumberg, S.J., Yeargin-Allsopp, M., Visser, S., and Kogan, M.D. (2011) Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics, 127 (6), 1034-1042.
38. Grandjean, P. and Heindel, J.J. (2008) In utero and early-life conditions and adult health and disease. N. Engl. J. Med., 359 (14), 1523. Author reply: 1524.
39. Hass, U. (2006) The need for developmental neurotoxicity studies in risk assessment for developmental toxicity. Reprod. Toxicol., 22 (2), 148-156.
40. Makris, S.L., Raffaele, K., Allen, S., Bowers, W.J., Hass, U., Alleva, E., Calamandrei, G., Sheets, L., Amcoff, P., Delrue, N., and Crofton, K.M. (2009) A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ. Health Perspect., 117 (1), 17-25.
41. U.S. EPA (1999) A set of scientific issues being considered by the Environmental Protection Agency regarding a retrospective analysis of developmental neurotoxicity studies. FIFRA SAP Report No. 99-01B, FIFRA Scientific Advisory Panel Meeting, 1998, Sheraton Crystal Hotel, Arlington, VA.
42. Goldman, L.R. and Koduru, S. (2000) Chemicals in the environment and developmental toxicity to children: a public health and policy perspective. Environ. Health Perspect., 108 (Suppl. 3), 443-448.
43. OECD (2007) Test Guideline 426. OECD Guideline for Testing of Chemicals: Developmental Neurotoxicity Study. p. 26.
44. Middaugh, L.D., Dow-Edwards, D., Li, A.A., Sandler, J.D., Seed, J., Sheets, L.P., Shuey, D.L., Slikker, W., Jr., Weisenburger, W.P., Wise, L.D., and Selwyn, M.R. (2003) Neurobehavioral assessment: a survey of use and value in safety assessment studies. Toxicol. Sci., 76 (2), 250-261.
45. Bottini, A.A., Amcoff, P., and Hartung, T. (2007) Food for thought . . . on globalisation of alternative methods. ALTEX, 24 (4), 255-269.
46. Kuegler, P.B., Zimmer, B., Waldmann, T., Baudis, B., Ilmjarv, S., Hescheler, J., Gaughwin, P., Brundin, P., Mundy, W., Bal-Price, A.K., Schrattenholz, A., Krause, K.H., van Thriel, C., Rao, M.S., Kadereit, S., and Leist, M. (2010) Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX, 27 (1), 17-42.
47. Krause, K.H., Thriel, C.van., De Sousa, P.A., Leist, M., and Hengstler, J.G. (2013) Monocrotophos in Gandaman village: India school lunch deaths and need for improved toxicity testing. Arch. Toxicol., 87 (10), 1877-1881.
48. Leist, M., Hasiwa, N., Daneshian, M., and Hartung, T. (2012) Validation and quality control of replacement alternatives - current status and future challenges. Toxicol. Res., 1 (1), 8-22.
49. Clancy, B., Finlay, B.L., Darlington, R.B., and Anand, K.J. (2007) Extrapolating brain development from experimental species to humans. Neurotoxicology, 28 (5), 931-937.
50. Gottmann, E., Kramer, S., Pfahringer, B., and Helma, C. (2001) Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. Environ. Health Perspect., 109 (5), 509-514.
51. Schardein, J.L., Schwetz, B.A., and Kenel, M.F. (1985) Species sensitivities and prediction of teratogenic potential. Environ. Health Perspect., 61, 55-67.
52. Wadman, M. (2006) Earlier drug tests on people could be unsafe, critics warn. Nat. Med., 12 (2), 153.
53. Mol, P.G., Arnardottir, A.H., Motola, D., Vrijlandt, P.J., Duijnhoven, R.G., Haaijer-Ruskamp, F.M., de Graeff, P.A., Denig, P., and Straus, S.M. (2013) Post-approval safety issues with innovative drugs: a European cohort study. Drug Saf., 36 (11), 1105-1115.
54. NRC (2007) Toxicity Testing in the 21st Century. A Vision and a Strategy. The National Research Council Committee on Toxicity Testing and Assessment of Environmental Agents, The National Academies Press, p. 196.
55. Leist, M., Hartung, T., and Nicotera, P. (2008) The dawning of a new age of toxicology. ALTEX, 25 (2), 103-114.
56. Balmer, N.V. and Leist, M. (2014) Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development. Basic Clin. Pharmacol. Toxicol. doi: 10.1111/bcpt.12203.
57. Bal-Price, A.K., Hogberg, H.T., Buzanska, L., Lenas, P., van Vliet, E., and Hartung, T. (2010) In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology, 31 (5), 545-554.
58. Bremer, S. and Hartung, T. (2004) The use of embryonic stem cells for regulatory developmental toxicity testing in vitro - the current status of test development. Curr. Pharm. Des., 10 (22), 2733-2747.
59. Leist, M. (2013) Use of transcriptome profiling in stem cell based test systems for reproductive toxicity. LINZ 2013 - EUSAAT 2013 - ESNATS Conference, ALTEX, Linz, p. 65.
60. Massague, J. and Chen, Y.G. (2000) Controlling TGF-beta signaling. Genes Dev., 14 (6), 627-644.
61. von Bubnoff, A. and Cho, K.W. (2001) Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev. Biol., 239 (1), 1-14.
62. Weinstein, D.C. and Hemmati-Brivanlou, A. (1997) Neural induction in Xenopus laevis: evidence for the default model. Curr. Opin. Neurobiol., 7 (1), 7-12.
63. Pera, E.M., Wessely, O., Li, S.Y., and De Robertis, E.M. (2001) Neural and head induction by insulin-like growth factor signals. Dev. Cell, 1 (5), 655-665.
64. Wilson, S.I., Rydstrom, A., Trimborn, T., Willert, K., Nusse, R., Jessell, T.M., and Edlund, T. (2001) The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature, 411 (6835), 325-330.
65. O'Rahilly, R. and Muller, F. (2007) The development of the neural crest in the human. J. Anat., 211 (3), 335-351.
66. Smith, J.L. and Schoenwolf, G.C. (1997) Neurulation: coming to closure. Trends Neurosci., 20 (11), 510-517.
67. Brand, A.H. and Livesey, F.J. (2011) Neural stem cell biology in vertebrates and invertebrates: more alike than different? Neuron, 70 (4), 719-729.
68. Conti, L. and Cattaneo, E. (2010) Neural stem cell systems: physiological players or in vitro entities? Nat. Rev. Neurosci., 11 (3), 176-187.
69. Gotz, M. and Huttner, W.B. (2005) The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol., 6 (10), 777-788.
70. Lui, J.H., Hansen, D.V., and Kriegstein, A.R. (2011) Development and evolution of the human neocortex. Cell, 146 (1), 18-36.
71. Greene, N.D., Stanier, P., and Copp, A.J. (2009) Genetics of human neural tube defects. Hum. Mol. Genet., 18 (R2), R113-R129.
72. Botto, L.D., Moore, C.A., Khoury, M.J., and Erickson, J.D. (1999) Neural-tube defects. N. Engl. J. Med., 341 (20), 1509-1519.
73. Wallingford, J.B., Niswander, L.A., Shaw, G.M., and Finnell, R.H. (2013) The continuing challenge of understanding, preventing, and treating neural tube defects. Science, 339 (6123), 1222002.
74. Ornoy, A., Zvi, N., Arnon, J., Wajnberg, R., Shechtman, S., and Diav-Citrin, O. (2008) The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies. Reprod. Toxicol., 25 (3), 388-389.
75. Le Douarin, N.M. and Dupin, E. (2003) Multipotentiality of the neural crest. Curr. Opin. Genet. Dev., 13 (5), 529-536.
76. Sauka-Spengler, T. and Bronner-Fraser, M. (2008) Evolution of the neural crest viewed from a gene regulatory perspective. Genesis, 46 (11), 673-682.
77. Menendez, L., Kulik, M.J., Page, A.T., Park, S.S., Lauderdale, J.D., Cunningham, M.L., and Dalton, S. (2013) Directed differentiation of human pluripotent cells to neural crest stem cells. Nat. Protoc., 8 (1), 203-212.
78. Trainor, P.A. (2010) Craniofacial birth defects: the role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention. Am. J. Med. Genet. A, 152A (12), 2984-2994.
79. Taraviras, S. and Pachnis, V. (1999) Development of the mammalian enteric nervous system. Curr. Opin. Genet. Dev., 9 (3), 321-327.
80. Amiel, J. and Lyonnet, S. (2001) Hirschsprung disease, associated syndromes, and genetics: a review. J. Med. Genet., 38 (11), 729-739.
81. Zimmer, B., Lee, G., Balmer, N.V., Meganathan, K., Sachinidis, A., Studer, L., and Leist, M. (2012) Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ. Health Perspect., 120 (8), 1116-1122.
82. Menegola, E., Broccia, M.L., Di Renzo, F., Prati, M., and Giavini, E. (2000) In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. In Vitro Cell Dev. Biol. Anim., 36 (2), 88-95.
83. Briscoe, J. and Novitch, B.G. (2008) Regulatory pathways linking progenitor patterning, cell fates and neurogenesis in the ventral neural tube. Philos. Trans. R. Soc. Lond. B Biol. Sci., 363 (1489), 57-70.
84. Jessell, T.M. (2000) Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet., 1 (1), 20-29.
85. Briscoe, J. and Therond, P.P. (2013) The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol., 14 (7), 416-429.
86. Hui, C.C. and Angers, S. (2011) Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol., 27, 513-537.
87. Zimmer, B., Kuegler, P.B., Baudis, B., Genewsky, A., Tanavde, V., Koh, W., Tan, B., Waldmann, T., Kadereit, S., and Leist, M. (2011) Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ., 18 (3), 383-395.
88. Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M., Ross, C.A., Hatten, M.E., Nakajima, K., and Sawa, A. (2005) A schizophreniaassociated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol., 7 (12), 1167-1178.
89. Oksenberg, N. and Ahituv, N. (2013) The role of AUTS2 in neurodevelopment and human evolution. Trends Genet., 29 (10), 600-608.
90. Bal-Price, A.K., Coecke, S., Costa, L., Crofton, K.M., Fritsche, E., Goldberg, A., Grandjean, P., Lein, P.J., Li, A., Lucchini, R., Mundy, W.R., Padilla, S., Persico, A. M., Seiler, A.E., and Kreysa, J. (2012) Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX, 29 (2), 202-215.
91. Crofton, K.M., Mundy, W.R., Lein, P.J., Bal-Price, A., Coecke, S., Seiler, A.E., Knaut, H., Buzanska, L., and Goldberg, A. (2011) Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX, 28 (1), 9-15.
92. Ankley, G.T., Bennett, R.S., Erickson, R.J., Hoff, D.J., Hornung, M.W., Johnson, R.D., Mount, D.R., Nichols, J.W., Russom, C.L., Schmieder, P.K., Serrrano, J.A., Tietge, J.E., and Villeneuve, D.L. (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem., 29 (3), 730-741.
93. Robinette, B.L., Harrill, J.A., Mundy, W.R., and Shafer, T.J. (2011) In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front. Neuroeng., 4, 1.
94. Leist, M., Ringwald, A., Kolde, R., Bremer, S., Thriel, C.van., Krause, K.H., Rahnenfuhrer, J., Sachinidis, A., Hescheler, J., and Hengstler, J.G. (2013) Test systems of developmental toxicity: state-of-the-art and future perspectives. Arch. Toxicol., 87 (12), 2037-2042.
95. Schenk, B., Weimer, M., Bremer, S., van der Burg, B., Cortvrindt, R., Freyberger, A., Lazzari, G., Pellizzer, C., Piersma, A., Schafer, W.R., Seiler, A., Witters, H., and Schwarz, M. (2010) The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod. Toxicol., 30 (1), 200-218.
96. Ramirez, T., Daneshian, M., Kamp, H., Bois, F.Y., Clench, M.R., Coen, M., Donley, B., Fischer, S.M., Ekman, D.R., Fabian, E., Guillou, C., Heuer, J., Hogberg, H.T., Jungnickel, H., Keun, H. C., Krennrich, G., Krupp, E., Luch, A., Noor, F., Peter, E., Riefke, B., Seymour, M., Skinner, N., Smirnova, L., Verheij, E., Wagner, S., Hartung, T., van Ravenzwaay, B., and Leist, M. (2013) Metabolomics in toxicology and preclinical research. ALTEX, 30 (2), 209-225.
97. Keller, D.A., Juberg, D.R., Catlin, N., Farland, W.H., Hess, F.G., Wolf, D.C., and Doerrer, N.G. (2012) Identification and characterization of adverse effects in 21st century toxicology. Toxicol. Sci., 126 (2), 291-297.
98. Pistollato, F., Bremer-Hoffmann, S., Healy, L., Young, L., and Stacey, G. (2012) Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin. Drug Metab. Toxicol., 8 (2), 239-257.
99. Chapin, R.E. and Stedman, D.B. (2009) Endless possibilities: stem cells and the vision for toxicology testing in the 21st century. Toxicol. Sci., 112 (1), 17-22.
100. Gassmann, K., Abel, J., Bothe, H., Haarmann-Stemmann, T., Merk, H.F., Quasthoff, K.N., Rockel, T.D., Schreiber, T., and Fritsche, E. (2010) Speciesspecific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ. Health Perspect., 118 (11), 1571-1577.
101. Kang, K.S. and Trosko, J.E. (2011) Stem cells in toxicology: fundamental biology and practical considerations. Toxicol. Sci., 120 (Suppl. 1), S269-S289.
102. Dubois-Dauphin, M.L., Toni, N., Julien, S.D., Charvet, I., Sundstrom, L.E., and Stoppini, L. (2010) The long-term survival of in vitro engineered nervous tissue derived from the specific neural differentiation of mouse embryonic stem cells. Biomaterials, 31 (27), 7032-7042.
103. Abranches, E., Silva, M., Pradier, L., Schulz, H., Hummel, O., Henrique, D., and Bekman, E. (2009) Neural differentiation of embryonic stem cells in vitro: a road map to neurogenesis in the embryo. PLoS One, 4 (7), e6286.
104. Nat, R. and Dechant, G. (2011) Milestones of directed differentiation of mouse and human embryonic stem cells into telencephalic neurons based on neural development in vivo. Stem Cells Dev., 20 (6), 947-958.
105. Carri, A.D., Onorati, M., Lelos, M.J., Castiglioni, V., Faedo, A., Menon, R., Camnasio, S., Vuono, R., Spaiardi, P., Talpo, F., Toselli, M., Martino, G., Barker, R.A., Dunnett, S.B., Biella, G., and Cattaneo, E. (2013) Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ mediumsized spiny neurons. Development, 140 (2), 301-312.
106. Elkabetz, Y., Panagiotakos, G., Shamy, G.Al., Socci, N.D., Tabar, V., and Studer, L. (2008) Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev., 22 (2), 152-165.
107. Fasano, C.A., Chambers, S.M., Lee, G., Tomishima, M.J., and Studer, L. (2010) Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell, 6 (4), 336-347.
108. Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P., and Knoblich, J.A. (2013) Cerebral organoids model human brain development and microcephaly. Nature, 501 (7467), 373-379.
109. Pellizzer, C., Bremer, S., and Hartung, T. (2005) Developmental toxicity testing from animal towards embryonic stem cells. ALTEX, 22 (2), 47-57.
110. van Dartel, D.A., Zeijen, N.J., de la Fonteyne, L.J., van Schooten, F.J., and Piersma, A.H. (2009) Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol. Reprod. Toxicol., 28 (2), 254-261.
111. Breier, J.M., Radio, N.M., Mundy, W.R., and Shafer, T.J. (2008) Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol. Sci., 105 (1), 119-133.
112. Moors, M., Rockel, T.D., Abel, J., Cline, J.E., Gassmann, K., Schreiber, T., Schuwald, J., Weinmann, N., and Fritsche, E. (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect., 117 (7), 1131-1138.
113. Krishnamoorthy, M., Gerwe, B.A., Scharer, C.D., Sahasranaman, V., Eilertson, C.D., Nash, R.J., Usta, S.N., Kelly, S., Rose, M., Peraza, R., Arumugham, J., Stewart, B., Stice, S.L., and Nash, R.J. (2013) Ethanol alters proliferation and differentiation of normal and chromosomally abnormal human embryonic stem cell-derived neurospheres. Birth. Defects Res. B Dev. Reprod. Toxicol., 98 (3), 283-295.
114. Hoelting, L., Scheinhardt, B., Bondarenko, O., Schildknecht, S., Kapitza, M., Tanavde, V., Tan, B., Lee, Q.Y., Mecking, S., Leist, M., and Kadereit, S. (2012) A 3-dimensional human embryonic stem cell (hESC)-derived model to detect developmental neurotoxicity of nanoparticles. Arch. Toxicol., 87 (4), 721-733.
115. Stummann, T.C., Hareng, L., and Bremer, S. (2009) Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. Toxicology, 257 (3), 117-126.
116. Kleinstreuer, N.C., Smith, A.M., West, P.R., Conard, K.R., Fontaine, B.R., Weir-Hauptman, A.M., Palmer, J.A., Knudsen, T.B., Dix, D.J., Donley, E.L., and Cezar, G.G. (2011) Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics. Toxicol. Appl. Pharmacol., 257 (1), 111-121.
117. West, P.R., Weir, A.M., Smith, A.M., Donley, E.L., and Cezar, G.G. (2010) Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol. Appl. Pharmacol., 247 (1), 18-27.
118. Robinson, J.F., Theunissen, P.T., van Dartel, D.A., Pennings, J.L., Faustman, E.M., and Piersma, A.H. (2011) Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reprod. Toxicol., 32 (2), 180-188.
119. Theunissen, P.T., Schulpen, S.H., van Dartel, D.A., Hermsen, S.A., van Schooten, F.J., and Piersma, A.H. (2010) An abbreviated protocol for multilineage neural differentiation of murine embryonic stem cells and its perturbation by methyl mercury. Reprod. Toxicol., 29 (4), 383-392.
120. Zimmer, B., Schildknecht, S., Kuegler, P.B., Tanavde, V., Kadereit, S., and Leist, M. (2011) Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. Toxicol. Sci., 121 (2), 357-367.
121. Waldmann, T., Rempel, E., Balmer, N.V., Konig, A., Kolde, R., Gaspar, J.A., Henry, M., Hescheler, J., Sachinidis, A., Rahnenfuhrer, J., Hengstler, J.G., and Leist, M. (2014) Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem. Res. Toxicol. doi: 10.1021/tx400402j.
122. Visan, A., Hayess, K., Sittner, D., Pohl, E.E., Riebeling, C., Slawik, B., Gulich, K., Oelgeschlager, M., Luch, A., and Seiler, A.E. (2012) Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro. Neurotoxicology, 33 (5), 1135-1146.
123. Harrill, J.A., Freudenrich, T.M., Machacek, D.W., Stice, S.L., and Mundy, W.R. (2011) Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology, 31 (3), 277-290.
124. Frimat, J.P., Sisnaiske, J., Subbiah, S., Menne, H., Godoy, P., Lampen, P., Leist, M., Franzke, J., Hengstler, J.G., Thriel, C.van., and West, J. (2010) The network formation assay: a spatially standardized neurite outgrowth analytical display for neurotoxicity screening. Lab Chip, 10 (6), 701-709.
125. Krug, A.K., Balmer, N.V., Matt, F., Schonenberger, F., Merhof, D., and Leist, M. (2013) Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch. Toxicol., 87 (12), 2215-2231.
126. Stiegler, N.V., Krug, A.K., Matt, F., and Leist, M. (2011) Assessment of chemicalinduced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol. Sci., 121 (1), 73-87.
127. Howard, A.S., Bucelli, R., Jett, D.A., Bruun, D., Yang, D., and Lein, P.J. (2005) Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol. Appl. Pharmacol., 207 (2), 112-124.
128. Kim, W.Y., Gonsiorek, E.A., Barnhart, C., Davare, M.A., Engebose, A.J., Lauridsen, H., Bruun, D., Lesiak, A., Wayman, G., Bucelli, R., Higgins, D., and Lein, P.J. (2009) Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation. J. Neurochem., 108 (4), 1057-1071.
129. Hernandez, R.V., Navarro, M.M., Rodriguez, W.A., Martinez, J.L., Jr., and LeBaron, R.G. (2005) Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number. Brain Res. Brain Res. Protoc., 15 (1), 6-13.
130. Dingemans, M.M., Ramakers, G.M., Gardoni, F., van Kleef, R.G., Bergman, A., Di Luca, M., van den Berg, M., Westerink, R.H., and Vijverberg, H.P. (2007) Neonatal exposure to brominated flame retardant BDE-47 reduces longterm potentiation and postsynaptic protein levels in mouse hippocampus. Environ. Health Perspect., 115 (6), 865-870.
131. Fukunaga, K., Stoppini, L., Miyamoto, E., and Muller, D. (1993) Long-term potentiation is associated with an increased activity of Ca2+/calmodulindependent protein kinase II. J. Biol. Chem., 268 (11), 7863-7867.
132. Chiappalone, M., Massobrio, P., and Martinoia, S. (2008) Network plasticity in cortical assemblies. Eur. J. Neurosci., 28 (1), 221-237.
133. Spira, M.E. and Hai, A. (2013) Multi-electrode array technologies for neuroscience and cardiology. Nat. Nanotechnol., 8 (2), 83-94.
134. Harrill, J.A., Robinette, B.L., and Mundy, W.R. (2011) Use of high content image analysis to detect chemicalinduced changes in synaptogenesis in vitro. Toxicol. In Vitro, 25 (1), 368-387.
135. Pouly, S., Storch, M.K., Matthieu, J.M., Lassmann, H., Monnet-Tschudi, F., and Honegger, P. (1997) Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures. J. Neurosci. Res., 49 (2), 121-132.
136. Zurich, M.G. and Monnet-Tschudi, F. (2009) Contribution of in vitro neurotoxicology studies to the elucidation of neurodegenerative processes. Brain Res. Bull., 80 (4-5), 211-216.
137. Defranchi, E., Novellino, A., Whelan, M., Vogel, S., Ramirez, T., van Ravenzwaay, B., and Landsiedel, R. (2011) Feasibility assessment of micro-electrode chip assay as a method of detecting neurotoxicity in vitro. Front. Neuroeng., 4, 6.
138. McConnell, E.R., McClain, M.A., Ross, J., Lefew, W.R., and Shafer, T.J. (2012) Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. Neurotoxicology, 33 (5), 1048-1057.
139. Hogberg, H.T., Sobanski, T., Novellino, A., Whelan, M., Weiss, D.G., and Bal-Price, A.K. (2011) Application of microelectrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acidinduced effects in primary cultures of rat cortical neurons. Neurotoxicology, 32 (1), 158-168.
140. van Vliet, E., Stoppini, L., Balestrino, M., Eskes, C., Griesinger, C., Sobanski, T., Whelan, M., Hartung, T., and Coecke, S. (2007) Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects. Neurotoxicology, 28 (6), 1136-1146.
141. Thiebaud, P., Rooij, N.F.de., Koudelka-Hep, M., and Stoppini, L. (1997) Microelectrode arrays for electrophysiological monitoring of hippocampal organotypic slice cultures. IEEE Trans. Biomed. Eng., 44 (11), 1159-1163.
142. Mack, C.M., Lin, B.J., Turner, J.D., Johnstone, A.F., Burgoon, L.D., and Shafer, T.J. (2014) Burst and principal components analyses of MEA data for 16 chemicals describe at least three effects classes. Neurotoxicology, 40, 75-85.
143. Yla-Outinen, L., Heikkila, J., Skottman, H., Suuronen, R., Aanismaa, R., and Narkilahti, S. (2010) Human cell-based micro electrode array platform for studying neurotoxicity. Front. Neuroeng. doi: 10.3389/fneng.2010.00111.
144. Monnet-Tschudi, F., Defaux, A., Braissant, O., Cagnon, L., and Zurich, M.G. (2011) Methods to assess neuroinflammation. Curr. Protoc. Toxicol., 12, 12.19.
145. Kuegler, P.B., Baumann, B.A., Zimmer, B., Keller, S., Marx, A., Kadereit, S., and Leist, M. (2012) GFAP-independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells. Glia, 60 (2), 218-228.
146. Hirt, U.A., Gantner, F., and Leist, M. (2000) Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol., 164 (12), 6520-6529.
147. Simon, B.M., Malisan, F., Testi, R., Nicotera, P., and Leist, M. (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ., 9 (7), 758-767.
148. Henn, A., Lund, S., Hedtjarn, M., Schrattenholz, A., Porzgen, P., and Leist, M. (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX, 26 (2), 83-94.
149. Henn, A., Kirner, S., and Leist, M. (2011) TLR2 hypersensitivity of astrocytes as functional consequence of previous inflammatory episodes. J. Immunol., 186 (5), 3237-3247.
150. Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.W., Price, A., Schechtman, L., Stacey, G., and Stokes, W. (Second ECVAM Task Force on Good Cell Culture Practice) (2005) Guidance on good cell culture practice. A report of the Second ECVAM Task Force on Good Cell Culture Practice. Altern. Lab. Anim., 33 (3), 261-287.
151. Leist, M., Efremova, L., and Karreman, C. (2010) Food for thought . . . considerations and guidelines for basic test method descriptions in toxicology. ALTEX, 27 (4), 309-317.
152. De Kock, J. (2012) Focus on stem cells as sources of human target cells for in vitro research and testing. ALTEX, 1 (1), 541-548.
153. Schreiber, T., Gassmann, K., Gotz, C., Hubenthal, U., Moors, M., Krause, G., Merk, H.F., Nguyen, N.H., Scanlan, T.S., Abel, J., Rose, C.R., and Fritsche, E. (2010) Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ. Health Perspect., 118 (4), 572-578.
154. Radio, N.M. and Mundy, W.R. (2008) Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology, 29 (3), 361-376.
155. Zimmer, B., Pallocca, G., Dreser, N., Foerster, S., Waldmann, T., Westerhout, J., Julien, S., Krause, K., van Thriel, C., Hengstler, J., Sachinidis, A., Bosgra, S., and Leist, M. (2014) Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. Arch. Toxicol., 88 (5), 1109-1126.
156. Stokes, W., McFarland, R., Kulpa-Eddy, J., Gatewood, D., Levis, R., Halder, M., Pulle, G., Kojima, H., Casey, W., Gaydamaka, A., Miller, T., Brown, K., Lewis, C., Chapsal, J.M., Bruckner, L., Gairola, S., Kamphuis, E., Rupprecht, C.E., Wunderli, P., McElhinney, L., De Mattia, F., Gamoh, K., Hill, R., Reed, D., Doelling, V., Johnson, N., Allen, D., Rinckel, L., and Jones, B. (2012) Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals, 40 (5), 369-381.
157. ICCVAM (1997) Validation and Regulatory Acceptance of Toxicological Test Methods: A Report of the Ad Hoc Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM).
158. ICCVAM (2003) ICCVAM Guidelines for the Nomination and Submission of New, Revised, and Alternative Test Methods.
159. OECD (2005) Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment.
160. Stokes, W.S. and Wind, M. (2010) Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities. ALTEX, 27 (3), 87-95.
161. Judson, R., Kavlock, R., Martin, M., Reif, D., Houck, K., Knudsen, T., Richard, A., Tice, R.R., Whelan, M., Xia, M., Huang, R., Austin, C., Daston, G., Hartung, T., Fowle, J.R., 3rd, Wooge, W., and Tong, W., and Dix, D. (2013) Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX, 30 (1), 51-56.
162. Hartung, T. (2007) Food for thought . . . on validation. ALTEX, 24 (2), 67-80.
163. Hartung, T., Hoffmann, S., and Stephens, M. (2013) Mechanistic validation. ALTEX, 30 (2), 119-130.
164. Blesa, J., Phani, S., Jackson-Lewis, V., and Przedborski, S. (2012) Classic and new animal models of Parkinson's disease. J. Biomed. Biotechnol., 2012, 845618.
165. Breier, J.M., Gassmann, K., Kayser, R., Stegeman, H., De Groot, D., Fritsche, E., and Shafer, T.J. (2010) Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol., 32 (1), 4-15.
166. Mullard, A. (2012) Oncology trials gear up for high-throughput sequencing. Nat. Rev. Drug Discov., 11 (5), 339-340.
167. Scannell, J.W., Blanckley, A., Boldon, H., and Warrington, B. (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov., 11 (3), 191-200.
168. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131 (5), 861-872.
169. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., and Thomson, J.A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science, 318 (5858), 1917-1920.
170. Han, D.W., Tapia, N., Hermann, A., Hemmer, K., Hoing, S., Arauzo-Bravo, M.J., Zaehres, H., Wu, G., Frank, S., Moritz, S., Greber, B., Yang, J.H., Lee, H. T., Schwamborn, J.C., Storch, A., and Scholer, H.R. (2012) Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell, 10 (4), 465-472.
171. Thier, M., Worsdorfer, P., Lakes, Y.B., Gorris, R., Herms, S., Opitz, T., Seiferling, D., Quandel, T., Hoffmann, P., Nothen, M.M., Brustle, O., and Edenhofer, F. (2012) Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell, 10 (4), 473-479.
172. Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Sudhof, T.C., and Wernig, M. (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463 (7284), 1035-1041.
173. Bellin, M., Marchetto, M.C., Gage, F.H., and Mummery, C.L. (2012) Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol., 13 (11), 713-726.
174. Grskovic, M., Javaherian, A., Strulovici, B., and Daley, G.Q. (2011) Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov., 10 (12), 915-929.
175. Marchetto, M.C. and Gage, F.H. (2012) Modeling brain disease in a dish: really? Cell Stem Cell, 10 (6), 642-645.
176. Trounson, A., Shepard, K.A., and DeWitt, N.D. (2012) Human disease modeling with induced pluripotent stem cells. Curr. Opin. Genet. Dev., 22 (5), 509-516.
177. Ebert, A.D., Yu, J., Rose, F.F., Jr., Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457 (7227), 277-280.
178. Ananiev, G., Williams, E.C., Li, H., and Chang, Q. (2011) Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One, 6 (9), e25255.
179. Farra, N., Zhang, W.B., Pasceri, P., Eubanks, J.H., Salter, M.W., and Ellis, J. (2012) Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol. Psychiatry, 17 (12), 1261-1271.
180. Koch, P., Breuer, P., Peitz, M., Jungverdorben, J., Kesavan, J., Poppe, D., Doerr, J., Ladewig, J., Mertens, J., Tuting, T., Hoffmann, P., Klockgether, T., Evert, B.O., Wullner, U., and Brustle, O. (2011) Excitation-induced ataxin-3 aggregation in neurons from patients with Machado- Joseph disease. Nature, 480 (7378), 543-546.
181. Nguyen, H.N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schule, B., Dolmetsch, R.E., Langston, W., Palmer, T.D., and Pera, R.R. (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell, 8 (3), 267-280.
182. Sanchez-Danes, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jimenez-Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A., Canals, J.M., Memo, M., Alberch, J., Lopez-Barneo, J., Vila, M., Cuervo, A.M., Tolosa, E., Consiglio, A., and Raya, A. (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol. Med., 4 (5), 380-395.
183. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., McCarthy, S., Sebat, J., and Gage, F.H. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473 (7346), 221-225.
184. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller, M., Croft, G.F., Amoroso, M.W., Oakley, D.H., Gnirke, A., Eggan, K., and Meissner, A. (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell, 144 (3), 439-452.
185. Hayden, E.C. (2011) Stem cells: the growing pains of pluripotency. Nature, 473 (7347), 272-274.
186. Shi, Y., Kirwan, P., Smith, J., Robinson, H.P., and Livesey, F.J. (2012) Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci., 15 (3), 477-486.
187. Abbott, A. (2003) Neuroscience: genomics on the brain. Nature, 426 (6968), 757.
188. Sundstrom, L., Biggs, T., Laskowski, A., and Stoppini, L. (2012) OrganDots - an organotypic 3D tissue culture platform for drug development. Expert Opin. Drug Discov., 7 (6), 525-534.
189. Preynat-Seauve, O., Suter, D.M., Tirefort, D., Turchi, L., Virolle, T., Chneiweiss, H., Foti, M., Lobrinus, J.A., Stoppini, L., Feki, A., Dubois-Dauphin, M., and Krause, K.H. (2009) Development of human nervous tissue upon differentiation of embryonic stem cells in threedimensional culture. Stem Cells, 27 (3), 509-520.
190. Mariani, J., Simonini, M.V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A.M., Horvath, T.L., and Vaccarino, F.M. (2012) Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA, 109 (31), 12770-12775.
191. Eskes, C., Juillerat-Jeanneret, L., Leuba, G., Honegger, P., and Monnet-Tschudi, F. (2003) Involvement of microglia- neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J. Neurosci. Res., 71 (4), 583-590.
192. Monnet-Tschudi, F., Zurich, M.G., Riederer, B.M., and Honegger, P. (1995) Effects of trimethyltin (TMT) on glial and neuronal cells in aggregate cultures: dependence on the developmental stage. Neurotoxicology, 16 (1), 97-104.
193. Sorg, O., Schilter, B., Honegger, P., and Monnet-Tschudi, F. (1998) Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation. Acta Neuropathol., 96 (6), 621-627.
194. Zurich, M.G., Monnet-Tschudi, F., and Honegger, P. (1994) Long-term treatment of aggregating brain cell cultures with low concentrations of lead acetate. Neurotoxicology, 15 (3), 715-719.
195. Honegger, P., Pardo, B., and Monnet-Tschudi, F. (1998) Muscimol-induced death of GABAergic neurons in rat brain aggregating cell cultures. Brain Res. Dev. Brain Res., 105 (2), 219-225.
196. Monnet-Tschudi, F., Hazekamp, A., Perret, N., Zurich, M.G., Mangin, P., Giroud, C., and Honegger, P. (2008) Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-typespecific adverse effects in aggregating brain cell cultures. Toxicol. Appl. Pharmacol., 228 (1), 8-16.
197. Pardo, B. and Honegger, P. (1999) High sensitivity of immature GABAergic neurons to blockers of voltage-gated calcium channels. Brain Res. Dev. Brain Res., 115 (1), 9-16.
198. Zurich, M.G., Honegger, P., Schilter, B., Costa, L.G., and Monnet-Tschudi, F. (2004) Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Toxicol. Appl. Pharmacol., 201 (2), 97-104.
199. Eskes, C., Honegger, P., Jones-Lepp, T., Varner, K., Matthieu, J.M., and Monnet-Tschudi, F. (1999) Neurotoxicity of dibutyltin in aggregating brain cell cultures. Toxicol. In Vitro, 13 (4-5), 555-560.
200. Monnet-Tschudi, F., Zurich, M.G., and Honegger, P. (1993) Evaluation of the toxicity of different metal compounds in the developing brain using aggregating cell cultures as a model. Toxicol. In Vitro, 7 (4), 335-339.
201. Zurich, M.G., Eskes, C., Honegger, P., Berode, M., and Monnet-Tschudi, F. (2002) Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions. J. Neurosci. Res., 70 (1), 108-116.
202. Zurich, M.G., Honegger, P., Schilter, B., Costa, L.G., and Monnet-Tschudi, F. (2000) Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. Neurotoxicology, 21 (4), 599-605.
203. Hill, E.J., Woehrling, E.K., Prince, M., and Coleman, M.D. (2008) Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. Toxicology, 249 (2-3), 243-250.
204. Vangipuram, S.D., Grever, W.E., Parker, G.C., and Lyman, W.D. (2008) Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. Alcohol. Clin. Exp. Res., 32 (2), 339-347.
205. Martinez, Y., Dubois-Dauphin, M., and Krause, K.H. (2012) Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. Front. Physiol., 3, 47.
206. Corbin, J.G., Gaiano, N., Juliano, S.L., Poluch, S., Stancik, E., and Haydar, T.F. (2008) Regulation of neural progenitor cell development in the nervous system. J. Neurochem., 106 (6), 2272-2287.
207. Oppenheim, R.W. (1991) Cell death during development of the nervous system. Annu. Rev. Neurosci., 14, 453-501.
208. Adlard, B.P., Dobbing, J., and Sands, J. (1975) A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat. Br. J. Pharmacol., 54 (1), 33-39.
209. Kuwagata, M., Takashima, H., and Nagao, T. (1998) A comparison of the in vivo and in vitro response of rat embryos to 5-fluorouracil. J. Vet. Med. Sci., 60 (1), 93-99.
210. Ciaroni, S., Cecchini, T., Ferri, P., Ambrogini, P., Cuppini, R., Lombardelli, G., Peruzzi, G., and Del Grande, P. (2002) Postnatal development of rat dentate gyrus: effects of methylazoxymethanol administration. Mech. Ageing Dev., 123 (5), 499-509.
211. Vaccarino, F.M., Ganat, Y., Zhang, Y., and Zheng, W. (2001) Stem cells in neurodevelopment and plasticity. Neuropsychopharmacology, 25 (6), 805-815.
212. Krug, A.K., Kolde, R., Gaspar, J.A., Rempel, E., Balmer, N.V., Meganathan, K., Vojnits, K., Baquie, M., Waldmann, T., Ensenat-Waser, R., Jagtap, S., Evans, R.M., Julien, S., Peterson, H., Zagoura, D., Kadereit, S., Gerhard, D., Sotiriadou, I., Heke, M., Natarajan, K., Henry, M., Winkler, J., Marchan, R., Stoppini, L., Bosgra, S., Westerhout, J., Verwei, M., Vilo, J., Kortenkamp, A., Hescheler, J., Hothorn, L., Bremer, S., van Thriel, C., Krause, K.H., Hengstler, J.G., Rahnenfuhrer, J., Leist, M., and Sachinidis, A. (2013) Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch. Toxicol., 87 (1), 123-143.
213. Robinson, J.F., Pennings, J.L., and Piersma, A.H. (2012) A review of toxicogenomic approaches in developmental toxicology. Methods Mol. Biol., 889, 347-371.
214. Hermsen, S.A., Pronk, T.E., van den Brandhof, E.J., van der Ven, L.T., and Piersma, A.H. (2012) Concentration- response analysis of differential gene expression in the zebrafish embryotoxicity test following flusilazole exposure. Toxicol. Sci., 127 (1), 303-312.
215. Hermsen, S.A., van den Brandhof, E.J., van der Ven, L.T., and Piersma, A.H. (2011) Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol. In Vitro, 25 (3), 745-753.
216. Kern, I., Xu, R., Julien, S., Suter, D.M., Preynat-Seauve, O., Baquie, M., Poncet, A., Combescure, C., Stoppini, L., Thriel, C.V., and Krause, K.H. (2013) Embryonic stem cell-based screen for small molecules: cluster analysis reveals four response patterns in developing neural cells. Curr. Med. Chem., 20 (5), 710-723.
217. Klemm, M. and Schrattenholz, A. (2004) Neurotoxicity of active compounds - establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification. ALTEX, 21 (Suppl. 3), 41-48.
218. van Vliet, E., Morath, S., Eskes, C., Linge, J., Rappsilber, J., Honegger, P., Hartung, T., and Coecke, S. (2008) A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology, 29 (1), 1-12.
219. Bayer, S.A. and Altman, J. (1991) Development of the endopiriform nucleus and the claustrum in the rat brain. Neuroscience, 45 (2), 391-412.
220. Kriegstein, A. and Alvarez-Buylla, A. (2009) The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci., 32, 149-184.
221. Marin, O., Valiente, M., Ge, X., and Tsai, L.H. (2010) Guiding neuronal cell migrations. Cold Spring Harb. Perspect. Biol., 2 (2), a001834.
222. Hallier-Vanuxeem, D., Prieto, P., Culot, M., Diallo, H., Landry, C., Tahti, H., and Cecchelli, R. (2009) New strategy for alerting central nervous system toxicity: integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment. Toxicol. In Vitro, 23 (3), 447-453.
223. O'Donnell, M., Chance, R.K., and Bashaw, G.J. (2009) Axon growth and guidance: receptor regulation and signal transduction. Annu. Rev. Neurosci., 32, 383-412.
224. Alfano, D.P. and Petit, T.L. (1982) Neonatal lead exposure alters the dendritic development of hippocampal dentate granule cells. Exp. Neurol., 75 (2), 275-288.
225. Choi, B.H., Kudo, M., and Lapham, L.W. (1981) A Golgi and electron-microscopic study of cerebellum in methylmercury- poisoned neonatal mice. Acta Neuropathol., 54 (3), 233-237.
226. Lotharius, J., Falsig, J., Beek, J.van., Payne, S., Dringen, R., Brundin, P., and Leist, M. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J. Neurosci., 25 (27), 6329-6342.
227. Scholz, D., Poltl, D., Genewsky, A., Weng, M., Waldmann, T., Schildknecht, S., and Leist, M. (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J. Neurochem., 119 (5), 957-971.
228. Colon-Ramos, D.A. (2009) Synapse formation in developing neural circuits. Curr. Top. Dev. Biol., 87, 53-79.
229. Abbott, L.F. and Nelson, S.B. (2000) Synaptic plasticity: taming the beast. Nat. Neurosci., 3 (Suppl.), 1178-1183.
230. Polleux, F., Ince-Dunn, G., and Ghosh, A. (2007) Transcriptional regulation of vertebrate axon guidance and synapse formation. Nat. Rev. Neurosci., 8 (5), 331-340.
231. Dingemans, M.M., de Groot, A., van Kleef, R.G., Bergman, A., van den Berg, M., Vijverberg, H.P., and Westerink, R.H. (2008) Hydroxylation increases the neurotoxic potential of BDE-47 to affect exocytosis and calcium homeostasis in PC12 cells. Environ. Health Perspect., 116 (5), 637-643.
232. Westerink, R.H. and Vijverberg, H.P. (2002) Toluene-induced, Ca2+)- dependent vesicular catecholamine release in rat PC12 cells. Neurosci. Lett., 326 (2), 81-84.
233. Nayagam, B.A., Edge, A.S., Needham, K., Hyakumura, T., Leung, J., Nayagam, D.A., and Dottori, M. (2013) An in vitro model of developmental synaptogenesis using cocultures of human neural progenitors and cochlear explants. Stem Cells Dev., 22 (6), 901-912.
234. Stoppini, L., Duport, S., and Correges, P. (1997) A new extracellular multirecording system for electrophysiological studies: application to hippocampal organotypic cultures. J. Neurosci. Methods, 72 (1), 23-33.
235. Wise, K.D., Najafi, K., and Drake, K.L. (1984) A multichannel probe for intracortical single-unit recording. IEEE Trans. Biomed. Eng., 31, 583-1583.
236. Gross, G.W., Rieske, E., Kreutzberg, G.W., and Meyer, A. (1977) A new fixed-array multi-microelectrode system designed for long-term monitoring of extracellular single unit neuronal activity in vitro. Neurosci. Lett., 6 (2-3), 101-105.
237. Pine, J. (1980) Recording action potentials from cultured neurons with extracellular microcircuit electrodes. J. Neurosci. Methods, 2 (1), 19-31.
238. Rutten, W. (2001) 'Rules of conduct': some practical guidelines for testing motor-nerve conduction. Arch. Physiol. Biochem., 109 (2), 191.
239. Rutten, W.L. (2002) Selective electrical interfaces with the nervous system. Annu. Rev. Biomed. Eng., 4, 407-452.
240. Novellino, A., Scelfo, B., Palosaari, T., Price, A., Sobanski, T., Shafer, T.J., Johnstone, A.F., Gross, G.W., Gramowski, A., Schroeder, O., Jugelt, K., Chiappalone, M., Benfenati, F., Martinoia, S., Tedesco, M.T., Defranchi, E., D'Angelo, P., and Whelan, M. (2011) Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front. Neuroeng., 4, 4.
241. Odawara, A., Saitoh, Y., Alhebshi, A.H., Gotoh, M., and Suzuki, I. (2014) Longterm electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture. Biochem. Biophys. Res. Commun., 443 (4), 1176-1181.
242. Suzuki, I., Fukuda, M., Shirakawa, K., Jiko, H., and Gotoh, M. (2013) Carbon nanotube multi-electrode array chips for noninvasive real-time measurement of dopamine, action potentials, and postsynaptic potentials. Biosens. Bioelectron., 49, 270-275.
243. Lefew, W.R., McConnell, E.R., Crooks, J.L., and Shafer, T.J. (2013) Evaluation of microelectrode array data using Bayesian modeling as an approach to screening and prioritization for neurotoxicity testing. Neurotoxicology, 36, 34-41.
244. Bunge, R.P. (1968) Glial cells and the central myelin sheath. Physiol. Rev., 48 (1), 197-251.
245. Miller, R.H. (2002) Regulation of oligodendrocyte development in the vertebrate CNS. Prog. Neurobiol., 67 (6), 451-467.
246. Nave, K.A. and Salzer, J.L. (2006) Axonal regulation of myelination by neuregulin 1. Curr. Opin. Neurobiol., 16 (5), 492-500.
247. Erceg, S., Ronaghi, M., Oria, M., Rosello, M.G., Arago, M.A., Lopez, M.G., Radojevic, I., Moreno-Manzano, V., Rodriguez-Jimenez, F.J., Bhattacharya, S.S., Cordoba, J., and Stojkovic, M. (2010) Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells, 28 (9), 1541-1549.
248. Guentert-Lauber, B., Monnet-Tschudi, F., Omlin, F.X., Favrod, P., and Honegger, P. (1985) Serum-free aggregate cultures of rat CNS glial cells: biochemical, immunocytochemical and morphological characterization. Dev. Neurosci., 7 (1), 33-44.
249. Chang, L.W. (1992) The concept of direct and indirect neurotoxicity and the concept of toxic metal/essential element interactions as a common biomechanism underlying metal toxicity, in The Vulnerable Brain and Environmental Risks (eds R.L. Isaacson and K.F. Jensen), Plenum Press, New York, p. 61-88.
250. Monnet-Tschudi, F., Zurich, M.G., and Honegger, P. (2007) Neurotoxicantinduced inflammatory response in three-dimensional brain cell cultures. Hum. Exp. Toxicol., 26 (4), 339-346.
251. Frank-Cannon, T.C., Alto, L.T., McAlpine, F.E., and Tansey, M.G. (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener., 4, 47.
252. Ransom, B.R., Kunis, D.M., Irwin, I., and Langston, J.W. (1987) Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci. Lett., 75 (3), 323-328.
253. Apati, A., Orban, T.I., Varga, N., Nemeth, A., Schamberger, A., Krizsik, V., Erdelyi-Belle, B., Homolya, L., Varady, G., Padanyi, R., Karaszi, E., Kemna, E.W., Nemet, K., and Sarkadi, B. (2008) High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim. Biophys. Acta, 1778 (12), 2700-2709.
254. Hyatt, M.A., Budge, H., and Symonds, M.E. (2008) Early developmental influences on hepatic organogenesis. Organogenesis, 4 (3), 170-175.